NCT03821272 2025-10-08A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer PatientsUniversity of ArkansasPhase 1/2 Completed17 enrolled 30 charts
NCT02356159 2025-09-30Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell TransplantationNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed34 enrolled 18 charts